Pulmonary Fibrosis News and Research

RSS
NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

NASDAQ halts trading of InterMune's common stock, FDA PADAC to discuss pirfenidone NDA

NASDAQ halts trading of InterMune's common stock, FDA PADAC to discuss pirfenidone NDA

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

InterMune seeks European marketing approval for pirfenidone

InterMune seeks European marketing approval for pirfenidone

CPF to partner with ATS to fund Pulmonary Fibrosis research

CPF to partner with ATS to fund Pulmonary Fibrosis research

IPF added to Social Security's "Compassionate Allowances" program

IPF added to Social Security's "Compassionate Allowances" program

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Fourth-quarter and full-year 2009 results announced by Compugen

Fourth-quarter and full-year 2009 results announced by Compugen

New study may allow scientists to develop screening test for idiopathic pulmonary fibrosis

New study may allow scientists to develop screening test for idiopathic pulmonary fibrosis

Celgene reports total revenue of $758M for fourth-quarter of 2009

Celgene reports total revenue of $758M for fourth-quarter of 2009

Palliative care program may complement patients' ongoing care with symptom management and support

Palliative care program may complement patients' ongoing care with symptom management and support

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

FDA grants Priority Review designation for InterMune's NDA for pirfenidone

FDA grants Priority Review designation for InterMune's NDA for pirfenidone

CPF reports success in advocacy, research support and awareness of PF

CPF reports success in advocacy, research support and awareness of PF

CPF, ATS and health groups launch campaign to raise awareness on lung health

CPF, ATS and health groups launch campaign to raise awareness on lung health

Findings raise new hope for asthma and chronic obstructive pulmonary disease

Findings raise new hope for asthma and chronic obstructive pulmonary disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.